Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,015Revenue $M274Net Margin (%)35.9Altman Z-Score37.1
Enterprise Value $M1,791EPS $1.6Operating Margin %54.8Piotroski F-Score6
P/E(ttm)14.9Beneish M-Score-1.9Pre-tax Margin (%)55.1Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %--Quick Ratio9.3Cash flow > EarningsN
Price/Sales5.35-y EBITDA Growth Rate %29.2Current Ratio10.5Lower Leverage y-yY
Price/Free Cash Flow22.5y-y EBITDA Growth Rate %238ROA % (ttm)36.5Higher Current Ratio y-yY
Dividend Yield %--PEG0.5ROE % (ttm)41.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M36.2ROIC % (ttm)79.4Gross Margin Increase y-yY

Gurus Latest Trades with LCI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
LCIJoel Greenblatt 2015-03-31 Add0.27%$41.29 - $69.82
$ 55.63-2%Add 51.63%1,555,795
LCIJoel Greenblatt 2014-12-31 Add0.25%$40.3 - $57.52
$ 55.6320%Add 238.24%1,026,029
LCIJoel Greenblatt 2014-09-30 Add0.12%$34.05 - $51.19
$ 55.6340%Add 749.49%303,345
LCIJoel Greenblatt 2014-06-30 Buy 0.02%$29.62 - $49.76
$ 55.6342%New holding35,709
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LCI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

LCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Maher James M.Director 2015-05-21Buy250$55.051.05view
BEDROSIAN ARTHUR PCEO 2015-05-15Sell5,000$53.274.43view
BEDROSIAN ARTHUR PCEO 2015-04-15Sell5,000$69.43-19.88view
BEDROSIAN ARTHUR PCEO 2015-03-16Sell5,000$65.23-14.72view
Schreck WilliamCOO 2015-03-16Sell134,635$64.99-14.4view
Schreck WilliamCOO 2015-03-12Sell16,177$65.1-14.55view
Schreck WilliamCOO 2015-03-06Sell50,000$63.35-12.19view
Taveira PaulDirector 2015-03-06Sell2,500$63.07-11.8view
Drabik David ADirector 2015-02-18Sell12,500$61.55-9.62view
Landis G. MichaelPrincipal Accounting Officer 2015-02-17Sell11,500$58.6-5.07view

Press Releases about LCI :

    Quarterly/Annual Reports about LCI:

    News about LCI:

    Articles On GuruFocus.com
    misc Apr 18 2015 
    Pharmaceutical Stock Picks For March Mar 04 2015 
    My Stocks Feb 13 2015 
    My Stocks Feb 13 2015 
    Lannett Company Looks Cheap At First Glance; But It Is Actually Much Cheaper Than It Looks Dec 29 2014 
    comment on LCI Nov 19 2012 
    comment on LCI Nov 13 2012 
    comment on LCI Jan 26 2012 
    comment on LCI Jan 26 2012 
    comment on LCI Jan 23 2012 

    More From Other Websites
    Regeneron, Lannett Among The 4 Top-Rated Drug Stocks May 28 2015
    Lightning Round: This is a one way ticket down May 21 2015
    Lannett (LCI) Signs Deal to Acquire Silarx Pharmaceuticals - Analyst Blog May 19 2015
    Celgene, Lannett Lead Boisterous Day For Drugmakers May 18 2015
    LANNETT CO INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... May 18 2015
    Lannett Signs Definitive Agreement To Acquire Silarx Pharmaceuticals, Inc. May 18 2015
    LANNETT CO INC Financials May 15 2015
    10-Q for Lannett Co., Inc. May 11 2015
    LANNETT CO INC Files SEC form 10-Q, Quarterly Report May 08 2015
    IBD Market Wrap - 05/07/15 May 07 2015
    LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial Condition May 07 2015
    Lannett beats 3Q profit forecasts May 06 2015
    Lannett beats 3Q profit forecasts May 06 2015
    Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results May 06 2015
    Q3 2015 Lannett Company Inc Earnings Release - After Market Close May 06 2015
    Lannett To Report Fiscal 2015 Third-Quarter Financial Results And Host Conference Call On Wednesday,... Apr 30 2015
    3 Mid-Cap Pharmaceutical Companies to Add to Your Portfolio Apr 28 2015
    LANNETT CO INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Apr 24 2015
    Lannett Expands Revolving Credit Facility To $120 Million Apr 24 2015
    Stop Worrying About A Correction And Do This Apr 22 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)